Drug Discovery AI vs Pepticom
Drug Discovery AI vs Pepticom, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Drug Discovery AI is on 17/100 and Pepticom on 55/100.
Where each one leads
Drug Discovery AI
- domain rating: 52/100 against 24/100
- headcount: 35 against 16
- LinkedIn following: 13,069 against 3,160
Pepticom
- our overall score: 55/100 against 17/100
At a glance
| Measure | Drug Discovery AI | Pepticom |
|---|---|---|
| What it is | AI platform accelerating the discovery of novel therapeutics. | AI platform for accelerating novel peptide therapeutic discovery and development. |
| Category | AI Drug Discovery, Biotech, HealthTech, Drug Discovery | Healthcare, Drug Discovery, Clinical Development, Peptide Drugs |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Software |
| Founded | 2023 | 2011 |
| Headquarters | Boston, United States | Jerusalem, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Drug Discovery AI | Pepticom |
|---|---|---|
| Employees | 35 | 16 |
| Headcount growthLast 12 months | Not published | -1.8% |
| Total funding | Not published | $7.6M |
| Latest round | Not published | Funding Round |
| LinkedIn followers | 13,069 | 3,160 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Drug Discovery AI | Pepticom |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 17/100 | 55/100 |
| Traction | 16/100 | 47/100 |
| Team | Not published | 70/100 |
| Search visibility | 22/100 | 33/100 |
| Quality | Not published | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 52/100 | 24/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Drug Discovery AI | Pepticom |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Google Analytics 4, Google Tag Manager |
Drug Discovery AI vs Pepticom: common questions
Which is better, Drug Discovery AI or Pepticom?
On our 0-100 score Pepticom rates higher (55/100 against 17/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Drug Discovery AI and Pepticom compare on the numbers?
Drug Discovery AI leads on domain rating (52/100 against 24/100), headcount (35 against 16), LinkedIn following (13,069 against 3,160). Pepticom leads on our overall score (55/100 against 17/100).
Read the full Drug Discovery AI review and pricing or the Pepticom review and pricing. You can also browse other Drug Discovery AI alternatives we track.